7 STRAITS VIEW, SINGAPORE, U0
Reg. FD
Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
News, Material Contracts
Investor Presentation
Reports Second Quarter 2025 Financial Results and Provides Business Update
Annual Report to Security Holders
Financial Results, Reg. FD
Announces Positive Data from FORWARD-53 Clinical Trial in DMD
Q2
Q1
Amended Annual Report
FY 2024
Q3
FY 2023 amended
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement